Compare AstraZeneca plc (AZN) vs Marriott International Inc (MAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Marriott International Inc — how do they compare? AstraZeneca plc trades at $158.42 (market cap $248.14B), while Marriott International Inc trades at $349.48 (market cap $91.14B). The key difference: AstraZeneca plc is far larger — about 2.7× Marriott International Inc 's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | MAR | |
|---|---|---|
Market Cap | $248.14B | $91.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $402.54 |
52-Week Low | $147.06 | $259.04 |
Enterprise Value | $275.41B | $108.45B |
Dividend Yield | 2.01% | 0.84% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →
